HCV-related mortality among male prison inmates in Texas, 1994-2003. 2009

Amy J Harzke, and Jacques G Baillargeon, and Michael F Kelley, and Pamela M Diamond, and Karen J Goodman, and David P Paar
Department of Preventive Medicine and Community Health and the Correctional Managed Care Division, University of Texas Medical Branch, Galveston, Texas 77555, USA. ajharzke@utmb.edu

OBJECTIVE The prevalence of hepatitis C virus (HCV) infection is high among adult incarcerated populations, but HCV-related mortality data are lacking. The study purpose was to assess HCV-related mortality over time and across racial/ethnic categories from 1994 through 2003 among male prisoners in the Texas Department of Criminal Justice (TDCJ). METHODS TDCJ decedent data were linked with Texas Vital Statistics multiple-cause-of-death data. Crude annual HCV death rates, age- and race-adjusted summary rates, and average annual percent changes were estimated. The proportion of deaths due to chronic liver disease/cirrhosis, liver cancer, hepatitis B, and HIV for which HCV was identified as an intervening or contributing cause of death was calculated. RESULTS Among Texas male prisoners, HCV death rates were high and increased over the 10-year study period by an average 21% annually, with the largest increase occurring among Hispanic prisoners. HCV was identified as an intervening or contributing cause of death in 15% of chronic liver disease/cirrhosis deaths, 33% of liver cancer deaths, 81% of hepatitis B deaths, and 7% of HIV deaths. CONCLUSIONS Because HCV-related deaths among Texas male prisoners are high and increasing, particularly among Hispanics, targeted prevention, screening, and treatment of HCV infections should be among the priorities of U.S. correctional healthcare systems.

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011330 Prisons Penal institutions, or places of long-term confinement for prisoners. Penitentiaries,Penitentiary,Prison
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Amy J Harzke, and Jacques G Baillargeon, and Michael F Kelley, and Pamela M Diamond, and Karen J Goodman, and David P Paar
June 1999, AIDS patient care and STDs,
Amy J Harzke, and Jacques G Baillargeon, and Michael F Kelley, and Pamela M Diamond, and Karen J Goodman, and David P Paar
April 2000, AIDS patient care and STDs,
Amy J Harzke, and Jacques G Baillargeon, and Michael F Kelley, and Pamela M Diamond, and Karen J Goodman, and David P Paar
June 2000, Texas medicine,
Amy J Harzke, and Jacques G Baillargeon, and Michael F Kelley, and Pamela M Diamond, and Karen J Goodman, and David P Paar
January 2020, International journal of law and psychiatry,
Amy J Harzke, and Jacques G Baillargeon, and Michael F Kelley, and Pamela M Diamond, and Karen J Goodman, and David P Paar
February 2000, Annals of epidemiology,
Amy J Harzke, and Jacques G Baillargeon, and Michael F Kelley, and Pamela M Diamond, and Karen J Goodman, and David P Paar
February 2000, Annals of epidemiology,
Amy J Harzke, and Jacques G Baillargeon, and Michael F Kelley, and Pamela M Diamond, and Karen J Goodman, and David P Paar
September 2008, Central European journal of public health,
Amy J Harzke, and Jacques G Baillargeon, and Michael F Kelley, and Pamela M Diamond, and Karen J Goodman, and David P Paar
January 1970, Dental survey,
Amy J Harzke, and Jacques G Baillargeon, and Michael F Kelley, and Pamela M Diamond, and Karen J Goodman, and David P Paar
December 1996, Epidemiology and infection,
Amy J Harzke, and Jacques G Baillargeon, and Michael F Kelley, and Pamela M Diamond, and Karen J Goodman, and David P Paar
May 2004, Preventive medicine,
Copied contents to your clipboard!